The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Cigna is the larger company, worth $70.9B, about 6.8 times Oscar Health.
  • Cigna grew revenue faster over the last year (+6.7% vs -6.2%).
  • Oscar Health keeps more of each dollar of revenue as operating profit (2128.9% vs 3.5%).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureCIOSCR
Market cap$70.9B$10.4B
Share price$282.43$33.37
Revenue (last fiscal year)$274.9B$29M
Free cash flow (last fiscal year)—$1.1B
Revenue growth, last year+6.7%-6.2%
Revenue growth per year, last 5 fiscal years+12.1%+51.7%
Operating margin3.5%2128.9%
Net margin2.3%1861.9%
Return on equity15.2%26.8%
P/E (trailing)11.1x—
Price / free cash flow8.45x9.86x
EV / EBITDA7.43x9.58x
FCF growth the price implies—-4.4%
Dividend yield2.2%—
Debt / equity2.68x4.47x
Fundamental gradeCC
Superinvestors holding it92
Insider purchases, last 12 months101

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Cigna

YearRevenueFree cash flowOp. margin
2021$174.1B—4.6%
2022$180.5B—4.7%
2023$195.3B—4.4%
2024$247.1B—3.8%
2025$274.9B—3.3%

Oscar Health

YearRevenueFree cash flowOp. margin
2021$5M-$208M-10094.2%
2022$65M$351M-908.5%
2023$21M-$298M-1103.4%
2024$21M$950M278.3%
2025$29M$1.1B-1386.2%

Where the revenue comes from

Cigna · by segments, 2025

Evernorth Health Services$235.0B83%
Cigna Healthcare$47.4B17%
Other Operations$674M0%

Oscar Health

No segment breakdown reported.

Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CI in Investingly

Questions

Which is bigger, Cigna or Oscar Health?

Cigna (CI), at $70.9B against $10.4B.

Which grows faster, CI or OSCR?

Cigna: revenue grew +6.7% over the last year, against -6.2%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.